SAN JOSE, Calif., June 17, 2020 (Newswire.com) - DynoSense Corp. announced today it that entered into a commercial agreement with Advent Holdings Inc., a Canadian-based company...
DynoSense | Wednesday June 17, 2020
SAN JOSE, Calif., June 17, 2020 (Newswire.com) – DynoSense Corp. announced today it that entered into a commercial agreement with Advent Holdings Inc., a Canadian-based company listed on TSX Venture Exchange, pursuant to which Advent, through a wholly owned Hong Kong subsidiary, will sell and distribute DynoSense’s products and services in Hong Kong and Macau under a license granted to it by DynoSense. Under the terms of the commercial agreement, Advent will pay $1 million CAD to DynoSense on or before June 30, 2020, half of which constitutes the advance payment for inventory of certain products. The initial term of the commercial agreement will be five years and may be renewed for an additional five one-year terms thereafter, subject to certain revenue targets being met at the time of each renewal. The commercial agreement is subject to acceptance by the TSX Venture Exchange.
DynoSense deploys smart AI-powered software tools, connected FDA cleared devices, personalized digital planning, HIPAA compliant platform, and 24/7/365 care support to make it easy for physicians to adopt Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Telecare in their practice to improve care and increase revenue. Its comprehensive solution has already been recognized by leading physicians who also love the deployment simplicity of its proven business model.
Alice Chiu, president and CEO of Advent, stated: “We believe that this opportunity will strategically build on Advent’s current mobile and Internet business by expanding into the digital health industry, which we felt is showing its tremendous growth opportunities in the post-COVID-19 pandemic crisis.”
“I am delighted by the prospect of expanding our revenue further into Asia, and later Canada, through this agreement with Advent,” said Saeed Azimi, Founder and Chief Executive Officer of DynoSense Corp. “Alice and her team share our vision and passion for better health through better care.”
“DynoSense has built outstanding technologies and capabilities for addressing the large market for remote care assessment and management,” said Paul Chau, Senior Partner of WI Harper Group, member of the board and a major early lead investor in DynoSense.
DynoSense’s solution has a market size exceeding $50B dollars, spanning multiple segments including elderly healthcare, remote chronic care, hospital discharge management, contract research organizations (CROs), and consumer health and wellness.
In this post-COVID-19 era, “A new era of cloud-based remote health monitoring and analysis systems is upon us,” said Lee Winters, MD. “This will radically change the practice of medicine in and usher new ways of caring for patients, especially those in outlying and rural locations.”
“41 Million deaths globally each year are caused by non-communicable diseases (NCDs), contributing 71% of all deaths globally. However, most of these diseases are preventable with innovative quality care that empowers individuals while connecting them with the right support,” said Dr. Peter Yan, Medical Director and Co-Founder WL&H, Cardiologist and Physician, MBBS (Singapore), M.Med (Int Med), FAMS (Cardiology).
About Advent Holdings Inc.:
Advent-AWI Holdings Inc., incorporated in 1984 and based in Vancouver, Canada, is listed on the TSX Venture Exchange (Symbol: AWI.V) together with its subsidiaries and provides cellular and wireless products, services, and accessories in Canada. The company operates through two segments, Wireless Business and Financing Business. The Wireless Business segment offers wireless voice and data, high-speed internet, digital cable television, home phone, smart home monitoring, and Rogers Bank Mastercard products. The Financing Business segment provides personal and collateral loans across the Greater Vancouver and Greater Toronto Areas.
About WI Harper Group:
Founded in 1993 by Peter Liu, WI Harper is a pioneering cross-border venture capital firm investing in early to growth-stage companies across the U.S., Greater China, and Asia-Pacific with more than 400 companies in the fields of healthcare, biotech, artificial intelligence, robotics, fintech, sustainability, and new media. WI Harper is actively overseeing more than $1 billion in assets under management with 100-plus successful IPO and M&A exits. Three offices in San Francisco, Beijing, and Taipei allow their stellar team of experts to identify and capitalize on opportunities both in the U.S. and Asia.
DynoSense is a growing global startup founded in Silicon Valley USA with a division in Nanjing, China, a technological innovator with the objective to improve and enable personalization, prediction, prevention, and participatory health & wellness through augmenting personalized care with Digital Therapeutics. This sophisticated AI-powered health management solutions, called Health Relationship Management Solution (HRMS) is comprised of patented tools such as a clinically validated, FDA-cleared vital sign measurement system and physiological and behavioral health assessment system to deliver better clinical and financial outcomes while creating a better experience for participating members.
Today, as part of the U.S. Food and Drug Administration’s ongoing efforts to address the coronavirus outbreak (COVID-19), the agency issued a new policy that...
DynoSense | Saturday March 21, 2020
Today, as part of the U.S. Food and Drug Administration’s ongoing efforts to address the coronavirus outbreak (COVID-19), the agency issued a new policy that allows manufacturers of certain FDA-cleared non-invasive, vital sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely. The devices include those that measure body temperature, respiratory rate, heart rate and blood pressure.
“Allowing these devices to be used remotely can help health care providers access information about a patient’s vital signs while the patient is at home, reducing the need for hospital visits and minimizing the risk of exposure to coronavirus,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D. “This policy reflects the FDA’s commitment to ease burdens on health care providers and facilities as they face this public health emergency. Such devices include technologies capable of enabling remote interactions to provide crucial information to be used as an adjunctive when health care providers diagnose or treat COVID-19 or co-existing conditions. During this public health emergency, it is imperative that the FDA provide regulatory relief and adapt as the situation warrants to act upon measures to save lives.”
This policy applies to certain modifications to the indications, claims, functionality, or hardware or software of FDA-cleared non-invasive remote monitoring devices used to support patient monitoring. This policy is limited to the duration of the emergency.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
Published Mar 2, 2016 by David Lee Scher Electronic health records (EHRs) have come to represent the face of digital health technology to most physicians,...
DynoSense | Friday February 7, 2020
Published Mar 2, 2016 by David Lee Scher
Electronic health records (EHRs) have come to represent the face of digital health technology to most physicians, but the dissatisfaction and frustration that physicians have experienced with EHRs is widespread. There are many things that physicians want but aren’t getting from their EHRs, such as communication and scheduling platforms, patient management, remote monitoring and reference tools. Security and privacy when using devices at work are major concerns as well in the healthcare space. Below are five ways mobile can improve the way doctors deliver care:
1. Security and privacy. Physicians frequently use smartphones to access patient records, as well as for communications throughout the day in both their professional and personal lives. With this in mind, healthcare presents unique considerations with regards to mobile privacy, security and keeping patient information safe. It’s important that application use policies are created and enforced, especially when it comes to facilities with BYOD policies. Containerization solutions, such as Samsung’s KNOX Workspace, allow care providers to separate their work and personal data on one device.
2.Patient scheduling tools. Both patients and physicians recognize the value of device-based appointment scheduling tools. Physicians are looking for tools that automate the scheduling process to decrease costs and no-shows. ZocDoc, an app-based tool that connects patients to the medical office, allows patients to make appointments online and helps practices to publicize their services and offer reminders. It’s been shown to decrease no-show rates and allows for seamless booking of open and canceled appointments.
3.Patient management medical apps. Apps that allow patients to follow and share data about their medical conditions, whether diabetes, asthma/COPD or heart health, are becoming commonly used by physicians. Patient management medical apps must also be able to connect to EHRs.
4.Remote patient monitoring. Longer-term data trends on weight, blood pressure, glucose measurements, heart rates and other parameters are often more valuable than snapshots obtained via periodic office visits, and can lead to better care and patient safety. For example, patients can view their insulin pump data on their smartphones, and wirelessly transmit data from implantable pacemakers and defibrillators. Remote patient monitoring is now available to physicians via mobile devices as well.
5. Reference tools, journals and continuing education. Another common use of mobile tools by physicians is for reference purposes. Medical reference data, textbooks, journal articles and sources of continuing medical education are more convenient and efficient to use when they can be accessed via mobile devices.
Physicians are technophiles. They’re also people whose lives outside medicine are significantly affected by mobile innovation. Healthcare is late to the game when it comes to technology because of its risk-averse culture and unique regulatory and business models. However, both patients and providers want healthcare to catch up when it comes to opportunities to add convenience and improve care.
To read full article, visit: https://insights.samsung.com/2016/03/02/5-things-physicians-want-from-mobile-technology/?eloquaid=CSEA2000001557227&elqTrackId=5eb45c7054b64413b59bfd4e08f51e59&elq=98cd62bfe81b455dbe39a91b0f9ac303&elqaid=652&elqat=1&elqCampaignId=301
San Jose, August 13, 2019 -- DynoSense Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its patented Vital...
DynoSense | Saturday December 14, 2019
San Jose, August 13, 2019 — DynoSense Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its patented Vital Signs Measuring System, the world’s first most integrated and cloud-based vital signs measuring and recording platform.
Its unique worldwide patented and award winning design is as simple to use as a digital thermometer yet capable of capturing electrocardiogram (ECG), respiration rate (RR), oral body temperature (TEMP), functional oxygen saturation of arterial hemoglobin (SpO2), optical photoplethysmogram (PPG) for pulse rate (PR), and heart rate (HR). The wireless device communicates with any smart mobile phone operating DynoLife application or third-party customized applications and sends the raw data to the cloud for computation. In contrast to traditional systems, the raw data is analyzed and results computed not in the device but in the cloud by an intelligent analytic (IA) engine with further capability to interpret other metrics including changes in blood pressure (BP), perfusion index (PI), different types of cardiac ailments such as Atrial Fibrillation (AFib), Heart Rate Variability (HRV), and other capabilities for its IA engine that are in various stages of development and testing.
Furthermore, DynoSense has built an advanced world-class intelligent software systems to offer patients clinically-based insights that make it easier to maintain optimal health. Its Health Relationship Management Services (HRMS) platform allows members of healthcare specialists team to aggregate and interpret health data and information to create actionable, personalized and timely individualized health care plans. Using the Medical Decision Support Algorithms (MDSA), companies can provide more comprehensive clinical and financial outcomes while creating a unique experience for people with high risk health factors or chronic conditions.
DynoSense HIPAA compliant health cloud (DYNOCLOUD) API, Software-as-a-Service (SaaS) platform, restructures data into a personalized and actionable information format to assist the care-experts to identify health conditions of concern and create individualized wellness plans. DYNOSCORE, an innovating new health scoring system, can predict clinical exacerbation days in advance of a critical event. Care providers are given access to a dashboard (DYNOCARE) where they can monitor the individual’s periodic measured status from the device, surveys, habits and receive alerts of unusual or troubling changes in a member’s routine. Members also have the option to communicate via text and video in our health social environment where they can receive support from care-experts and care-friends.
“I am very proud of our technological accomplishments and proven capabilities to date” said Saeed Azimi, Founder and Chief Executive Officer of DynoSense Corp. “We are on the path to take advantage of the shift to advanced AI based monitoring systems and Digital Therapeutics methods to improve health and wellness. As a person with my own chronic health condition, I have come to understand the power of receiving informed preventive and self-empowering alerts that are coupled with my clinical care specialists”.
With these advances in health technologies one can induce positive behavior to improve the human health condition. DynoSense is well positioned to be working with various organizations worldwide to further mature its technology and make them fully commercially ready and available by the first half of 2020. The company has collected over 100,000 data sets from various trials and is extending datasets in collaboration with partners.
“DynoSense has built incredibly strong advanced technologies and capabilities for addressing large nascent market in the Asia region” said Ryan Wong, CEO of Evvo Labs Pte Ltd. “We are planning for exciting business opportunities and go to market strategies with them.”
DynoSense´s solution has a market size exceeding $50B USD spanning multiple segments including elderly healthcare, chronic care, hospital discharge management, geographically isolated regions, contract research organizations (CROs), and consumer health and wellness.
“A new era of cloud based health monitoring and analysis systems is upon us” said Lee Winters, MD, professor of medicine and Silicon Valley biotech consultant “This will radically change the practice of medicine and usher in new ways of caring for patients especially those in outlying and rural locations.”
“Each year around 40 Million deaths globally are caused by Non-Communicable Diseases (NCDs). This accounts for approximately 68% of all deaths globally. However, most of these NCDs are preventable with innovative quality care that empowers individuals while connecting them with the right support.” Said Dr. Peter Yan, Senior Consultant Cardiologist and Physician, MBBS (Singapore), M.Med (Int Med), FAMS (Cardiology), Medical Director and Co-Founder of the Wellness Lifestyle & Health Group (WL&H), a company focused on precision wellness. “WL&H intends to be the leader in improving health and disease free longevity, that is why we have partnered with DynoSense to provide us with customized solutions based on their technologies”.
DynoSense is a growing global private company founded in Silicon Valley, USA with a division in Nanjing China that is on a mission to advance health assessment and health management solutions. DynoSense is a technological innovator with the objective to improve and enable personalization, prediction, prevention, and participatory health & wellness through augmenting personalized care with Digital Therapeutics for better management of patients with high risk health concerns and complex chronic conditions. This sophisticated AI optimized health management solutions, called Health Relationship Management Services (HRMS) is comprised of patented tools such as clinically-validated vital signs measurement, a physiological and behavioral health assessment system coupled with health management and engagement to deliver superior clinical and financial outcomes while creating a better experience for people with chronic conditions. For more information on DynoSense and its products, please visit: www.dynosense.com.
# # #
Abstract: Pregnant women can use Smartphone apps, social media, and remote health monitoring devices to provide security, confidence, and information about the condition of not...
DynoSense | Tuesday November 12, 2019
Pregnant women can use Smartphone apps, social media, and remote health monitoring devices to provide security, confidence, and information about the condition of not only their own health, but also that of the baby. Pregnant women can easily gain information about nutrition, complications, and fetal development using current technologies that can provide tips and alerts for preventive care, emergency-care, post-delivery support, and information about emerging risks. Remote monitoring of high risk pregnancy and prevention of preterm labor can now be done in the patient’s home using telehealth devices. Remote monitoring of high risk pregnancy and prevention of preterm labor can now be done in the patient’s home using telehealth, as well as the non-stress test (NST) is a common test done on patients with high risk pregnancy to identify fetus heart rate (FHR) for fetuses that are in immediate danger . Several apps are available on smartphones for pregnant women that offer support and track the health of both the mother and the fetus. The Dyno, a remote health monitoring system can track the mother’s health and alert caregivers if action is required.
Readmore by downloading pdf below
Do you want to learn what the most innovative company for last year recognized by Silicon Valley chamber of commerce is about to launch? Do...
DynoSense | Thursday February 28, 2019
Do you want to learn what the most innovative company for last year recognized by Silicon Valley chamber of commerce is about to launch? Do you want to hear what network of renowned medical advisors has to say about the Adore – the first Artificial Intelligent body composition monitoring system? would love to give you advanced access to our press release. See below the link to the press release as well as press kit:
We would love to give you advanced access to our press release. Download the attached pdf.
We’re looking forward to answering any questions you may have, let us know your interest.